EMEA (Europe, Middle East and Africa) Radiopharmaceuticals in Nuclear Medicine Market Report 2017

October 2017 | 129 pages | ID: EF612271423EN
QYResearch

Abstracts

In this report, the EMEA Radiopharmaceuticals in Nuclear Medicine market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Radiopharmaceuticals in Nuclear Medicine for these regions, from 2012 to 2022 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Radiopharmaceuticals in Nuclear Medicine market competition by top manufacturers/players, with Radiopharmaceuticals in Nuclear Medicine sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including

• Bracco Imaging S.P.A.
• Cambridge Isotope Laboratories, Inc.
• Cardinal Health, Inc.
• Covidien, Plc
• Eczacibasi-Monrol
• Fujifilm Holdings Corporation
• GE Healthcare (Subsidiary Of General Electric Company)
• IBA Group
• Isotec, Inc. (Sigma-Aldrich)
• Lantheus Medical Imaging, Inc.
• Nordion, Inc.
• Ntp Radioisotopes (Pty), Ltd.
• Siemens Healthcare (Subsidiary Of Siemens AG)
• Taiyo Nippon Sanso Corporation
• Urenco Limited
• Rotem Industries, Ltd., Inc.
• Australian Nuclear Association And Technology Organization (ANSTO)
• Board of Radiation And Isotope Technology (BRIT)
• Institute of Atomic Energy Polatom Radioisotope Centre
• Institute of Isotopes Co., Ltd.
• Institute Of Radioelement (IRE)

On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into

• Diagnostic Radiopharmaceuticals
• Therapy Radiopharmaceuticals
• Enriched Stable Isotopes

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of Radiopharmaceuticals in Nuclear Medicine for each application, including

• Diagnostic Application
• Therapeutic Application
• Research
• Pharmaceutical
• Other

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) Radiopharmaceuticals in Nuclear Medicine Market Report 2017

1 RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE OVERVIEW

1.1 Product Overview and Scope of Radiopharmaceuticals in Nuclear Medicine
1.2 Classification of Radiopharmaceuticals in Nuclear Medicine
  1.2.1 EMEA Radiopharmaceuticals in Nuclear Medicine Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 EMEA Radiopharmaceuticals in Nuclear Medicine Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Diagnostic Radiopharmaceuticals
  1.2.4 Therapy Radiopharmaceuticals
  1.2.5 Enriched Stable Isotopes
1.3 EMEA Radiopharmaceuticals in Nuclear Medicine Market by Application/End Users
  1.3.1 EMEA Radiopharmaceuticals in Nuclear Medicine Sales (Volume) and Market Share Comparison by Application (2012-2022
  1.3.2 Diagnostic Application
  1.3.3 Therapeutic Application
  1.3.4 Research
  1.3.5 Pharmaceutical
  1.3.6 Other
1.4 EMEA Radiopharmaceuticals in Nuclear Medicine Market by Region
  1.4.1 EMEA Radiopharmaceuticals in Nuclear Medicine Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 Middle East Status and Prospect (2012-2022)
  1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Radiopharmaceuticals in Nuclear Medicine (2012-2022)
  1.5.1 EMEA Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2012-2022)
  1.5.2 EMEA Radiopharmaceuticals in Nuclear Medicine Revenue and Growth Rate (2012-2022)

2 EMEA RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Radiopharmaceuticals in Nuclear Medicine Market Competition by Players/Manufacturers
  2.1.1 EMEA Radiopharmaceuticals in Nuclear Medicine Sales Volume and Market Share of Major Players (2012-2017)
  2.1.2 EMEA Radiopharmaceuticals in Nuclear Medicine Revenue and Share by Players (2012-2017)
  2.1.3 EMEA Radiopharmaceuticals in Nuclear Medicine Sale Price by Players (2012-2017)
2.2 EMEA Radiopharmaceuticals in Nuclear Medicine (Volume and Value) by Type/Product Category
  2.2.1 EMEA Radiopharmaceuticals in Nuclear Medicine Sales and Market Share by Type (2012-2017)
  2.2.2 EMEA Radiopharmaceuticals in Nuclear Medicine Revenue and Market Share by Type (2012-2017)
  2.2.3 EMEA Radiopharmaceuticals in Nuclear Medicine Sale Price by Type (2012-2017)
2.3 EMEA Radiopharmaceuticals in Nuclear Medicine (Volume) by Application
2.4 EMEA Radiopharmaceuticals in Nuclear Medicine (Volume and Value) by Region
  2.4.1 EMEA Radiopharmaceuticals in Nuclear Medicine Sales and Market Share by Region (2012-2017)
  2.4.2 EMEA Radiopharmaceuticals in Nuclear Medicine Revenue and Market Share by Region (2012-2017)
  2.4.3 EMEA Radiopharmaceuticals in Nuclear Medicine Sales Price by Region (2012-2017)

3 EUROPE RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Radiopharmaceuticals in Nuclear Medicine Sales and Value (2012-2017)
  3.1.1 Europe Radiopharmaceuticals in Nuclear Medicine Sales Volume and Growth Rate (2012-2017)
  3.1.2 Europe Radiopharmaceuticals in Nuclear Medicine Revenue and Growth Rate (2012-2017)
3.2 Europe Radiopharmaceuticals in Nuclear Medicine Sales and Market Share by Type
3.3 Europe Radiopharmaceuticals in Nuclear Medicine Sales and Market Share by Application
3.4 Europe Radiopharmaceuticals in Nuclear Medicine Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Radiopharmaceuticals in Nuclear Medicine Sales Volume by Countries (2012-2017)
  3.4.2 Europe Radiopharmaceuticals in Nuclear Medicine Revenue by Countries (2012-2017)
  3.4.3 Germany Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2012-2017)
  3.4.4 France Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2012-2017)
  3.4.5 UK Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2012-2017)
  3.4.6 Russia Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2012-2017)
  3.4.7 Italy Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2012-2017)
  3.4.8 Benelux Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2012-2017)

4 MIDDLE EAST RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Radiopharmaceuticals in Nuclear Medicine Sales and Value (2012-2017)
  4.1.1 Middle East Radiopharmaceuticals in Nuclear Medicine Sales Volume and Growth Rate (2012-2017)
  4.1.2 Middle East Radiopharmaceuticals in Nuclear Medicine Revenue and Growth Rate (2012-2017)
4.2 Middle East Radiopharmaceuticals in Nuclear Medicine Sales and Market Share by Type
4.3 Middle East Radiopharmaceuticals in Nuclear Medicine Sales and Market Share by Application
4.4 Middle East Radiopharmaceuticals in Nuclear Medicine Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Radiopharmaceuticals in Nuclear Medicine Sales Volume by Countries (2012-2017)
  4.4.2 Middle East Radiopharmaceuticals in Nuclear Medicine Revenue by Countries (2012-2017)
  4.4.3 Saudi Arabia Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2012-2017)
  4.4.4 Israel Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2012-2017)
  4.4.5 UAE Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2012-2017)
  4.4.6 Iran Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2012-2017)

5 AFRICA RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Radiopharmaceuticals in Nuclear Medicine Sales and Value (2012-2017)
  5.1.1 Africa Radiopharmaceuticals in Nuclear Medicine Sales Volume and Growth Rate (2012-2017)
  5.1.2 Africa Radiopharmaceuticals in Nuclear Medicine Revenue and Growth Rate (2012-2017)
5.2 Africa Radiopharmaceuticals in Nuclear Medicine Sales and Market Share by Type
5.3 Africa Radiopharmaceuticals in Nuclear Medicine Sales and Market Share by Application
5.4 Africa Radiopharmaceuticals in Nuclear Medicine Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Radiopharmaceuticals in Nuclear Medicine Sales Volume by Countries (2012-2017)
  5.4.2 Africa Radiopharmaceuticals in Nuclear Medicine Revenue by Countries (2012-2017)
  5.4.3 South Africa Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2012-2017)
  5.4.4 Nigeria Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2012-2017)
  5.4.5 Egypt Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2012-2017)
  5.4.6 Algeria Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2012-2017)

6 EMEA RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 Bracco Imaging S.P.A.
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Radiopharmaceuticals in Nuclear Medicine Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Bracco Imaging S.P.A. Radiopharmaceuticals in Nuclear Medicine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Cambridge Isotope Laboratories, Inc.
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Radiopharmaceuticals in Nuclear Medicine Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Cambridge Isotope Laboratories, Inc. Radiopharmaceuticals in Nuclear Medicine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Cardinal Health, Inc.
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Radiopharmaceuticals in Nuclear Medicine Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Cardinal Health, Inc. Radiopharmaceuticals in Nuclear Medicine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Covidien, Plc
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Radiopharmaceuticals in Nuclear Medicine Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Covidien, Plc Radiopharmaceuticals in Nuclear Medicine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Eczacibasi-Monrol
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Radiopharmaceuticals in Nuclear Medicine Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medicine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Fujifilm Holdings Corporation
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Radiopharmaceuticals in Nuclear Medicine Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medicine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 GE Healthcare (Subsidiary Of General Electric Company)
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Radiopharmaceuticals in Nuclear Medicine Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medicine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 IBA Group
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Radiopharmaceuticals in Nuclear Medicine Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 IBA Group Radiopharmaceuticals in Nuclear Medicine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Isotec, Inc. (Sigma-Aldrich)
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Radiopharmaceuticals in Nuclear Medicine Product Type, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Isotec, Inc. (Sigma-Aldrich) Radiopharmaceuticals in Nuclear Medicine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Lantheus Medical Imaging, Inc.
  6.10.1 Company Basic Information, Manufacturing Base and Competitors
  6.10.2 Radiopharmaceuticals in Nuclear Medicine Product Type, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Lantheus Medical Imaging, Inc. Radiopharmaceuticals in Nuclear Medicine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 Nordion, Inc.
6.12 Ntp Radioisotopes (Pty), Ltd.
6.13 Siemens Healthcare (Subsidiary Of Siemens AG)
6.14 Taiyo Nippon Sanso Corporation
6.15 Urenco Limited
6.16 Rotem Industries, Ltd., Inc.
6.17 Australian Nuclear Association And Technology Organization (ANSTO)
6.18 Board of Radiation And Isotope Technology (BRIT)
6.19 Institute of Atomic Energy Polatom Radioisotope Centre
6.20 Institute of Isotopes Co., Ltd.
6.21 Institute Of Radioelement (IRE)

7 RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MANUFACTURING COST ANALYSIS

7.1 Radiopharmaceuticals in Nuclear Medicine Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Radiopharmaceuticals in Nuclear Medicine

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Radiopharmaceuticals in Nuclear Medicine Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Radiopharmaceuticals in Nuclear Medicine Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA RADIOPHARMACEUTICALS IN NUCLEAR MEDICINE MARKET FORECAST (2017-2022)

11.1 EMEA Radiopharmaceuticals in Nuclear Medicine Sales, Revenue and Price Forecast (2017-2022)
  11.1.1 EMEA Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate Forecast (2017-2022)
  11.1.2 EMEA Radiopharmaceuticals in Nuclear Medicine Revenue and Growth Rate Forecast (2017-2022)
  11.1.3 EMEA Radiopharmaceuticals in Nuclear Medicine Price and Trend Forecast (2017-2022)
11.2 EMEA Radiopharmaceuticals in Nuclear Medicine Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Radiopharmaceuticals in Nuclear Medicine Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Radiopharmaceuticals in Nuclear Medicine Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Radiopharmaceuticals in Nuclear Medicine Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Radiopharmaceuticals in Nuclear Medicine Sales Forecast by Type (2017-2022)
11.7 EMEA Radiopharmaceuticals in Nuclear Medicine Sales Forecast by Application (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Radiopharmaceuticals in Nuclear Medicine
Figure EMEA Radiopharmaceuticals in Nuclear Medicine Sales Volume (K Units) by Type (2012-2022)
Figure EMEA Radiopharmaceuticals in Nuclear Medicine Sales Volume Market Share by Type (Product Category) in 2016
Figure Diagnostic Radiopharmaceuticals Product Picture
Figure Therapy Radiopharmaceuticals Product Picture
Figure Enriched Stable Isotopes Product Picture
Figure EMEA Radiopharmaceuticals in Nuclear Medicine Sales Volume (K Units) by Application (2012-2022)
Figure EMEA Sales Market Share of Radiopharmaceuticals in Nuclear Medicine by Application in 2016
Figure Diagnostic Application Examples
Table Key Downstream Customer in Diagnostic Application
Figure Therapeutic Application Examples
Table Key Downstream Customer in Therapeutic Application
Figure Research Examples
Table Key Downstream Customer in Research
Figure Pharmaceutical Examples
Table Key Downstream Customer in Pharmaceutical
Figure Other Examples
Table Key Downstream Customer in Other
Figure EMEA Radiopharmaceuticals in Nuclear Medicine Market Size (Million USD) by Region (2012-2022)
Figure Europe Radiopharmaceuticals in Nuclear Medicine Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Radiopharmaceuticals in Nuclear Medicine Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Radiopharmaceuticals in Nuclear Medicine Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Radiopharmaceuticals in Nuclear Medicine Revenue (Million USD) Status and Forecast by Countries
Figure Africa Radiopharmaceuticals in Nuclear Medicine Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Radiopharmaceuticals in Nuclear Medicine Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Radiopharmaceuticals in Nuclear Medicine Sales Volume and Growth Rate (2012-2022)
Figure EMEA Radiopharmaceuticals in Nuclear Medicine Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Radiopharmaceuticals in Nuclear Medicine Market Major Players Product Sales Volume (K Units) (2012-2017)
Table EMEA Radiopharmaceuticals in Nuclear Medicine Sales Volume (K Units) of Major Players (2012-2017)
Table EMEA Radiopharmaceuticals in Nuclear Medicine Sales Share by Players (2012-2017)
Figure 2016 Radiopharmaceuticals in Nuclear Medicine Sales Share by Players
Figure 2017 Radiopharmaceuticals in Nuclear Medicine Sales Share by Players
Figure EMEA Radiopharmaceuticals in Nuclear Medicine Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Radiopharmaceuticals in Nuclear Medicine Revenue (Million USD) by Players (2012-2017)
Table EMEA Radiopharmaceuticals in Nuclear Medicine Revenue Share by Players (2012-2017)
Table 2016 EMEA Radiopharmaceuticals in Nuclear Medicine Revenue Share by Players
Table 2017 EMEA Radiopharmaceuticals in Nuclear Medicine Revenue Share by Players
Table EMEA Radiopharmaceuticals in Nuclear Medicine Sale Price (USD/Unit) by Players (2012-2017)
Table EMEA Radiopharmaceuticals in Nuclear Medicine Sales (K Units) and Market Share by Type (2012-2017)
Table EMEA Radiopharmaceuticals in Nuclear Medicine Sales Share by Type (2012-2017)
Figure Sales Market Share of Radiopharmaceuticals in Nuclear Medicine by Type (2012-2017)
Figure EMEA Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Type (2012-2017)
Table EMEA Radiopharmaceuticals in Nuclear Medicine Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Radiopharmaceuticals in Nuclear Medicine Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Radiopharmaceuticals in Nuclear Medicine by Type in 2016
Table EMEA Radiopharmaceuticals in Nuclear Medicine Sale Price (USD/Unit) by Type (2012-2017)
Table EMEA Radiopharmaceuticals in Nuclear Medicine Sales (K Units) and Market Share by Application (2012-2017)
Table EMEA Radiopharmaceuticals in Nuclear Medicine Sales Share by Application (2012-2017)
Figure Sales Market Share of Radiopharmaceuticals in Nuclear Medicine by Application (2012-2017)
Figure EMEA Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Application in 2016
Table EMEA Radiopharmaceuticals in Nuclear Medicine Sales (K Units) and Market Share by Region (2012-2017)
Table EMEA Radiopharmaceuticals in Nuclear Medicine Sales Share by Region (2012-2017)
Figure Sales Market Share of Radiopharmaceuticals in Nuclear Medicine by Region (2012-2017)
Figure EMEA Radiopharmaceuticals in Nuclear Medicine Sales Market Share in 2016
Table EMEA Radiopharmaceuticals in Nuclear Medicine Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Radiopharmaceuticals in Nuclear Medicine Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Radiopharmaceuticals in Nuclear Medicine by Region (2012-2017)
Figure EMEA Radiopharmaceuticals in Nuclear Medicine Revenue Market Share Regions in 2016
Table EMEA Radiopharmaceuticals in Nuclear Medicine Sales Price (USD/Unit) by Region (2012-2017)
Figure Europe Radiopharmaceuticals in Nuclear Medicine Sales (K Units) and Growth Rate (2012-2017)
Figure Europe Radiopharmaceuticals in Nuclear Medicine Revenue and Growth Rate (2012-2017)
Table Europe Radiopharmaceuticals in Nuclear Medicine Sales (K Units) by Type (2012-2017)
Table Europe Radiopharmaceuticals in Nuclear Medicine Market Share by Type (2012-2017)
Figure Europe Radiopharmaceuticals in Nuclear Medicine Market Share by Type in 2016
Table Europe Radiopharmaceuticals in Nuclear Medicine Sales (K Units) by Application (2012-2017)
Table Europe Radiopharmaceuticals in Nuclear Medicine Market Share by Application (2012-2017)
Figure Europe Radiopharmaceuticals in Nuclear Medicine Market Share by Application in 2016
Table Europe Radiopharmaceuticals in Nuclear Medicine Sales (K Units) by Countries (2012-2017)
Table Europe Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Countries (2012-2017)
Figure Europe Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Countries (2012-2017)
Figure Europe Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Countries in 2016
Table Europe Radiopharmaceuticals in Nuclear Medicine Revenue (Million USD) by Countries (2012-2017)
Table Europe Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Countries (2012-2017)
Figure Europe Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Countries (2012-2017)
Figure Europe Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Countries in 2016
Figure Germany Radiopharmaceuticals in Nuclear Medicine Sales (K Units) and Growth Rate (2012-2017)
Figure France Radiopharmaceuticals in Nuclear Medicine Sales (K Units) and Growth Rate (2012-2017)
Figure UK Radiopharmaceuticals in Nuclear Medicine Sales (K Units) and Growth Rate (2012-2017)
Figure Russia Radiopharmaceuticals in Nuclear Medicine Sales (K Units) and Growth Rate (2012-2017)
Figure Italy Radiopharmaceuticals in Nuclear Medicine Sales (K Units) and Growth Rate (2012-2017)
Figure Benelux Radiopharmaceuticals in Nuclear Medicine Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East Radiopharmaceuticals in Nuclear Medicine Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East Radiopharmaceuticals in Nuclear Medicine Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Radiopharmaceuticals in Nuclear Medicine Sales (K Units) by Type (2012-2017)
Table Middle East Radiopharmaceuticals in Nuclear Medicine Market Share by Type (2012-2017)
Figure Middle East Radiopharmaceuticals in Nuclear Medicine Market Share by Type (2012-2017)
Table Middle East Radiopharmaceuticals in Nuclear Medicine Sales (K Units) by Applications (2012-2017)
Table Middle East Radiopharmaceuticals in Nuclear Medicine Market Share by Applications (2012-2017)
Figure Middle East Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Application in 2016
Table Middle East Radiopharmaceuticals in Nuclear Medicine Sales Volume (K Units) by Countries (2012-2017)
Table Middle East Radiopharmaceuticals in Nuclear Medicine Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Radiopharmaceuticals in Nuclear Medicine Sales Volume Market Share by Countries in 2016
Table Middle East Radiopharmaceuticals in Nuclear Medicine Revenue (Million USD) by Countries (2012-2017)
Table Middle East Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Countries (2012-2017)
Figure Middle East Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Countries (2012-2017)
Figure Middle East Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Countries in 2016
Figure Saudi Arabia Radiopharmaceuticals in Nuclear Medicine Sales (K Units) and Growth Rate (2012-2017)
Figure Israel Radiopharmaceuticals in Nuclear Medicine Sales (K Units) and Growth Rate (2012-2017)
Figure UAE Radiopharmaceuticals in Nuclear Medicine Sales (K Units) and Growth Rate (2012-2017)
Figure Iran Radiopharmaceuticals in Nuclear Medicine Sales (K Units) and Growth Rate (2012-2017)
Figure Africa Radiopharmaceuticals in Nuclear Medicine Sales (K Units) and Growth Rate (2012-2017)
Figure Africa Radiopharmaceuticals in Nuclear Medicine Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Radiopharmaceuticals in Nuclear Medicine Sales (K Units) by Type (2012-2017)
Table Africa Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Type (2012-2017)
Figure Africa Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Type (2012-2017)
Figure Africa Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Type in 2016
Table Africa Radiopharmaceuticals in Nuclear Medicine Sales (K Units) by Application (2012-2017)
Table Africa Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Application (2012-2017)
Figure Africa Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Application (2012-2017)
Table Africa Radiopharmaceuticals in Nuclear Medicine Sales Volume (K Units) by Countries (2012-2017)
Table Africa Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Countries (2012-2017)
Figure Africa Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Countries (2012-2017)
Figure Africa Radiopharmaceuticals in Nuclear Medicine Sales Market Share by Countries in 2016
Table Africa Radiopharmaceuticals in Nuclear Medicine Revenue (Million USD) by Countries (2012-2017)
Table Africa Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Countries (2012-2017)
Figure Africa Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Countries (2012-2017)
Figure Africa Radiopharmaceuticals in Nuclear Medicine Revenue Market Share by Countries in 2016
Figure South Africa Radiopharmaceuticals in Nuclear Medicine Sales (K Units) and Growth Rate (2012-2017)
Figure Nigeria Radiopharmaceuticals in Nuclear Medicine Sales (K Units) and Growth Rate (2012-2017)
Figure Egypt Radiopharmaceuticals in Nuclear Medicine Sales (K Units) and Growth Rate (2012-2017)
Figure Algeria Radiopharmaceuticals in Nuclear Medicine Sales (K Units) and Growth Rate (2012-2017)
Table Bracco Imaging S.P.A. Radiopharmaceuticals in Nuclear Medicine Basic Information List
Table Bracco Imaging S.P.A. Radiopharmaceuticals in Nuclear Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Bracco Imaging S.P.A. Radiopharmaceuticals in Nuclear Medicine Sales (K Units) and Growth Rate (2012-2017)
Figure Bracco Imaging S.P.A. Radiopharmaceuticals in Nuclear Medicine Sales Market Share in EMEA (2012-2017)
Figure Bracco Imaging S.P.A. Radiopharmaceuticals in Nuclear Medicine Revenue Market Share in EMEA (2012-2017)
Table Cambridge Isotope Laboratories, Inc. Radiopharmaceuticals in Nuclear Medicine Basic Information List
Table Cambridge Isotope Laboratories, Inc. Radiopharmaceuticals in Nuclear Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Cambridge Isotope Laboratories, Inc. Radiopharmaceuticals in Nuclear Medicine Sales (K Units) and Growth Rate (2012-2017)
Figure Cambridge Isotope Laboratories, Inc. Radiopharmaceuticals in Nuclear Medicine Sales Market Share in EMEA (2012-2017)
Figure Cambridge Isotope Laboratories, Inc. Radiopharmaceuticals in Nuclear Medicine Revenue Market Share in EMEA (2012-2017)
Table Cardinal Health, Inc. Radiopharmaceuticals in Nuclear Medicine Basic Information List
Table Cardinal Health, Inc. Radiopharmaceuticals in Nuclear Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Cardinal Health, Inc. Radiopharmaceuticals in Nuclear Medicine Sales (K Units) and Growth Rate (2012-2017)
Figure Cardinal Health, Inc. Radiopharmaceuticals in Nuclear Medicine Sales Market Share in EMEA (2012-2017)
Figure Cardinal Health, Inc. Radiopharmaceuticals in Nuclear Medicine Revenue Market Share in EMEA (2012-2017)
Table Covidien, Plc Radiopharmaceuticals in Nuclear Medicine Basic Information List
Table Covidien, Plc Radiopharmaceuticals in Nuclear Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Covidien, Plc Radiopharmaceuticals in Nuclear Medicine Sales (K Units) and Growth Rate (2012-2017)
Figure Covidien, Plc Radiopharmaceuticals in Nuclear Medicine Sales Market Share in EMEA (2012-2017)
Figure Covidien, Plc Radiopharmaceuticals in Nuclear Medicine Revenue Market Share in EMEA (2012-2017)
Table Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medicine Basic Information List
Table Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medicine Sales (K Units) and Growth Rate (2012-2017)
Figure Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medicine Sales Market Share in EMEA (2012-2017)
Figure Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medicine Revenue Market Share in EMEA (2012-2017)
Table Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medicine Basic Information List
Table Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medicine Sales (K Units) and Growth Rate (2012-2017)
Figure Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medicine Sales Market Share in EMEA (2012-2017)
Figure Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medicine Revenue Market Share in EMEA (2012-2017)
Table GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medicine Basic Information List
Table GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medicine Sales (K Units) and Growth Rate (2012-2017)
Figure GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medicine Sales Market Share in EMEA (2012-2017)
Figure GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medicine Revenue Market Share in EMEA (2012-2017)
Table IBA Group Radiopharmaceuticals in Nuclear Medicine Basic Information List
Table IBA Group Radiopharmaceuticals in Nuclear Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure IBA Group Radiopharmaceuticals in Nuclear Medicine Sales (K Units) and Growth Rate (2012-2017)
Figure IBA Group Radiopharmaceuticals in Nuclear Medicine Sales Market Share in EMEA (2012-2017)
Figure IBA Group Radiopharmaceuticals in Nuclear Medicine Revenue Market Share in EMEA (2012-2017)
Table Isotec, Inc. (Sigma-Aldrich) Radiopharmaceuticals in Nuclear Medicine Basic Information List
Table Isotec, Inc. (Sigma-Aldrich) Radiopharmaceuticals in Nuclear Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Isotec, Inc. (Sigma-Aldrich) Radiopharmaceuticals in Nuclear Medicine Sales (K Units) and Growth Rate (2012-2017)
Figure Isotec, Inc. (Sigma-Aldrich) Radiopharmaceuticals in Nuclear Medicine Sales Market Share in EMEA (2012-2017)
Figure Isotec, Inc. (Sigma-Aldrich) Radiopharmaceuticals in Nuclear Medicine Revenue Market Share in EMEA (2012-2017)
Table Lantheus Medical Imaging, Inc. Radiopharmaceuticals in Nuclear Medicine Basic Information List
Table Lantheus Medical Imaging, Inc. Radiopharmaceuticals in Nuclear Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Lantheus Medical Imaging, Inc. Radiopharmaceuticals in Nuclear Medicine Sales (K Units) and Growth Rate (2012-2017)
Figure Lantheus Medical Imaging, Inc. Radiopharmaceuticals in Nuclear Medicine Sales Market Share in EMEA (2012-2017)
Figure Lantheus Medical Imaging, Inc. Radiopharmaceuticals in Nuclear Medicine Revenue Market Share in EMEA (2012-2017)
Table Nordion, Inc. Radiopharmaceuticals in Nuclear Medicine Basic Information List
Table Ntp Radioisotopes (Pty), Ltd. Radiopharmaceuticals in Nuclear Medicine Basic Information List
Table Siemens Healthcare (Subsidiary Of Siemens AG) Radiopharmaceuticals in Nuclear Medicine Basic Information List
Table Taiyo Nippon Sanso Corporation Radiopharmaceuticals in Nuclear Medicine Basic Information List
Table Urenco Limited Radiopharmaceuticals in Nuclear Medicine Basic Information List
Table Rotem Industries, Ltd., Inc. Radiopharmaceuticals in Nuclear Medicine Basic Information List
Table Australian Nuclear Association And Technology Organization (ANSTO) Radiopharmaceuticals in Nuclear Medicine Basic Information List
Table Board of Radiation And Isotope Technology (BRIT) Radiopharmaceuticals in Nuclear Medicine Basic Information List
Table Institute of Atomic Energy Polatom Radioisotope Centre Radiopharmaceuticals in Nuclear Medicine Basic Information List
Table Institute of Isotopes Co., Ltd. Radiopharmaceuticals in Nuclear Medicine Basic Information List
Table Institute Of Radioelement (IRE) Radiopharmaceuticals in Nuclear Medicine Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Radiopharmaceuticals in Nuclear Medicine
Figure Manufacturing Process Analysis of Radiopharmaceuticals in Nuclear Medicine
Figure Radiopharmaceuticals in Nuclear Medicine Industrial Chain Analysis
Table Raw Materials Sources of Radiopharmaceuticals in Nuclear Medicine Major Manufacturers in 2016
Table Major Buyers of Radiopharmaceuticals in Nuclear Medicine
Table Distributors/Traders List
Figure EMEA Radiopharmaceuticals in Nuclear Medicine Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure EMEA Radiopharmaceuticals in Nuclear Medicine Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Radiopharmaceuticals in Nuclear Medicine Price (USD/Unit) and Trend Forecast (2017-2022)
Table EMEA Radiopharmaceuticals in Nuclear Medicine Sales (K Units) Forecast by Region (2017-2022)
Figure EMEA Radiopharmaceuticals in Nuclear Medicine Sales Market Share Forecast by Region (2017-2022)
Table EMEA Radiopharmaceuticals in Nuclear Medicine Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Radiopharmaceuticals in Nuclear Medicine Revenue Market Share Forecast by Region (2017-2022)
Table Europe Radiopharmaceuticals in Nuclear Medicine Sales (K Units) Forecast by Countries (2017-2022)
Figure Europe Radiopharmaceuticals in Nuclear Medicine Sales Market Share Forecast by Countries (2017-2022)
Table Europe Radiopharmaceuticals in Nuclear Medicine Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Radiopharmaceuticals in Nuclear Medicine Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Radiopharmaceuticals in Nuclear Medicine Sales (K Units) Forecast by Countries (2017-2022)
Figure Middle East Radiopharmaceuticals in Nuclear Medicine Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Radiopharmaceuticals in Nuclear Medicine Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Radiopharmaceuticals in Nuclear Medicine Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Radiopharmaceuticals in Nuclear Medicine Sales (K Units) Forecast by Countries (2017-2022)
Figure Africa Radiopharmaceuticals in Nuclear Medicine Sales Market Share Forecast by Countries (2017-2022)
Table Africa Radiopharmaceuticals in Nuclear Medicine Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Radiopharmaceuticals in Nuclear Medicine Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Radiopharmaceuticals in Nuclear Medicine Sales (K Units) Forecast by Type (2017-2022)
Figure EMEA Radiopharmaceuticals in Nuclear Medicine Sales Market Share Forecast by Type (2017-2022)
Table EMEA Radiopharmaceuticals in Nuclear Medicine Sales (K Units) Forecast by Application (2017-2022)
Figure EMEA Radiopharmaceuticals in Nuclear Medicine Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources